These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 21820033)

  • 1. Post-translational modification of the androgen receptor.
    Gioeli D; Paschal BM
    Mol Cell Endocrinol; 2012 Apr; 352(1-2):70-8. PubMed ID: 21820033
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Posttranslational modification of the androgen receptor in prostate cancer.
    van der Steen T; Tindall DJ; Huang H
    Int J Mol Sci; 2013 Jul; 14(7):14833-59. PubMed ID: 23863692
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulating Androgen Receptor Function in Prostate Cancer: Exploring the Diversity of Post-Translational Modifications.
    Lumahan LEV; Arif M; Whitener AE; Yi P
    Cells; 2024 Jan; 13(2):. PubMed ID: 38275816
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Post-translational modifications of nuclear receptors and human disease.
    Anbalagan M; Huderson B; Murphy L; Rowan BG
    Nucl Recept Signal; 2012; 10():e001. PubMed ID: 22438791
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of the androgen receptor by post-translational modifications.
    Coffey K; Robson CN
    J Endocrinol; 2012 Nov; 215(2):221-37. PubMed ID: 22872761
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SUMO-specific protease 1 (SENP1) reverses the hormone-augmented SUMOylation of androgen receptor and modulates gene responses in prostate cancer cells.
    Kaikkonen S; Jääskeläinen T; Karvonen U; Rytinki MM; Makkonen H; Gioeli D; Paschal BM; Palvimo JJ
    Mol Endocrinol; 2009 Mar; 23(3):292-307. PubMed ID: 19116244
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ARD1/NAA10 acetylation in prostate cancer.
    Kuhns KJ; Zhang G; Wang Z; Liu W
    Exp Mol Med; 2018 Jul; 50(7):1-8. PubMed ID: 30054487
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The androgen receptor acetylation site regulates cAMP and AKT but not ERK-induced activity.
    Fu M; Rao M; Wu K; Wang C; Zhang X; Hessien M; Yeung YG; Gioeli D; Weber MJ; Pestell RG
    J Biol Chem; 2004 Jul; 279(28):29436-49. PubMed ID: 15123687
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Androgen receptor post-translational modifications and their implications for pathology.
    Montoya-Novoa I; Gardeazábal-Torbado JL; Alegre-Martí A; Fuentes-Prior P; Estébanez-Perpiñá E
    Biochem Soc Trans; 2024 Aug; 52(4):1673-1694. PubMed ID: 38958586
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acetylation of androgen receptor by ARD1 promotes dissociation from HSP90 complex and prostate tumorigenesis.
    DePaolo JS; Wang Z; Guo J; Zhang G; Qian C; Zhang H; Zabaleta J; Liu W
    Oncotarget; 2016 Nov; 7(44):71417-71428. PubMed ID: 27659526
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The in vivo role of androgen receptor SUMOylation as revealed by androgen insensitivity syndrome and prostate cancer mutations targeting the proline/glycine residues of synergy control motifs.
    Mukherjee S; Cruz-Rodríguez O; Bolton E; Iñiguez-Lluhí JA
    J Biol Chem; 2012 Sep; 287(37):31195-206. PubMed ID: 22829593
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epidermal-growth-factor-dependent phosphorylation and ubiquitinylation of MAGE-11 regulates its interaction with the androgen receptor.
    Bai S; Wilson EM
    Mol Cell Biol; 2008 Mar; 28(6):1947-63. PubMed ID: 18212060
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SUMO3 modification by PIAS1 modulates androgen receptor cellular distribution and stability.
    Yang N; Liu S; Qin T; Liu X; Watanabe N; Mayo KH; Li J; Li X
    Cell Commun Signal; 2019 Nov; 17(1):153. PubMed ID: 31752909
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Androgen receptor phosphorylation: biological context and functional consequences.
    Koryakina Y; Ta HQ; Gioeli D
    Endocr Relat Cancer; 2014 Aug; 21(4):T131-45. PubMed ID: 24424504
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epigenetic modification-dependent androgen receptor occupancy facilitates the ectopic TSPY1 expression in prostate cancer cells.
    Leng X; Liu M; Tao D; Yang B; Zhang Y; He T; Xie S; Wang Z; Liu Y; Yang Y
    Cancer Sci; 2021 Feb; 112(2):691-702. PubMed ID: 33185915
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cyclin-dependent kinase 5 modulates STAT3 and androgen receptor activation through phosphorylation of Ser⁷²⁷ on STAT3 in prostate cancer cells.
    Hsu FN; Chen MC; Lin KC; Peng YT; Li PC; Lin E; Chiang MC; Hsieh JT; Lin H
    Am J Physiol Endocrinol Metab; 2013 Oct; 305(8):E975-86. PubMed ID: 23941877
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential regulation of androgen receptor by PIM-1 kinases via phosphorylation-dependent recruitment of distinct ubiquitin E3 ligases.
    Linn DE; Yang X; Xie Y; Alfano A; Deshmukh D; Wang X; Shimelis H; Chen H; Li W; Xu K; Chen M; Qiu Y
    J Biol Chem; 2012 Jun; 287(27):22959-68. PubMed ID: 22584579
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Androgen receptor signalling in prostate cancer: the functional consequences of acetylation.
    Lavery DN; Bevan CL
    J Biomed Biotechnol; 2011; 2011():862125. PubMed ID: 21274273
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Coregulator recruitment and histone modifications in transcriptional regulation by the androgen receptor.
    Kang Z; Jänne OA; Palvimo JJ
    Mol Endocrinol; 2004 Nov; 18(11):2633-48. PubMed ID: 15308689
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of androgen receptor SUMOylation.
    Rytinki MM; Kaikkonen S; Sutinen P; Palvimo JJ
    Methods Mol Biol; 2011; 776():183-97. PubMed ID: 21796528
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.